With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

Study objectives: To identify the predictors of medication adherence in patients with COPD and contrast the health beliefs, experiences, and behaviors of COPD patients self-reporting good ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

Opens in a new tab or window Share on X. Opens in a new tab or ... "This may inform prescribing of glucose-lowering medications among patients with T2D and active COPD," making SGLT2 and GLP ...

Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive ...

The research, published in the Journal of the COPD Foundation ... which often are treated with fall-risk increasing drugs.

The risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is and with GLP-1 RAs versus DPP-4is.

Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a recent study. The research is published in Chronic ...

COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle approaches can help. When you have COPD, medications can go a long way to help you ...

"These findings suggest that SGLT-2is and GLP-1 RAs may be preferable to DPP4is when deciding among glucose-lowering medications for patients with T2D and active COPD," the authors write.